AMENDED AND RESTATED RETENTION AGREEMENTRetention Agreement • June 19th, 2020 • Obalon Therapeutics Inc • Surgical & medical instruments & apparatus • California
Contract Type FiledJune 19th, 2020 Company Industry JurisdictionThis Amended and Restated Retention Agreement (the “Agreement”) is entered into by and between Andrew Rasdal (the “Executive”) and Obalon Therapeutics, Inc., a Delaware corporation (the “Company”), effective as of June 9, 2020 (the “Effective Date”). This Agreement amends and restates in its entirety that certain Retention Agreement, dated as of October 10, 2016, by and between the Executive and the Company (the “Original Agreement”). The Executive agrees that, as of the Effective Date, the Original Agreement shall be terminated and of no further force or effect and shall be superseded by this Agreement.
AMENDED AND RESTATED RETENTION AGREEMENTRetention Agreement • June 19th, 2020 • Obalon Therapeutics Inc • Surgical & medical instruments & apparatus • California
Contract Type FiledJune 19th, 2020 Company Industry JurisdictionThis Amended and Restated Retention Agreement (the “Agreement”) is entered into by and between Nooshin Hussainy (the “Executive”) and Obalon Therapeutics, Inc., a Delaware corporation (the “Company”), effective as of June 9, 2020 (the “Effective Date”). This Agreement amends and restates in its entirety that certain Retention Agreement, dated as of October 10, 2016, by and between the Executive and the Company (the “Original Agreement”). The Executive agrees that, as of the Effective Date, the Original Agreement shall be terminated and of no further force or effect and shall be superseded by this Agreement.